BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18588888)

  • 1. Stathmin/Op18 is a novel mediator of vinblastine activity.
    Devred F; Tsvetkov PO; Barbier P; Allegro D; Horwitz SB; Makarov AA; Peyrot V
    FEBS Lett; 2008 Jul; 582(17):2484-8. PubMed ID: 18588888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stathmin potentiates vinflunine and inhibits Paclitaxel activity.
    Malesinski S; Tsvetkov PO; Kruczynski A; Peyrot V; Devred F
    PLoS One; 2015; 10(6):e0128704. PubMed ID: 26030092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
    Alli E; Bash-Babula J; Yang JM; Hait WN
    Cancer Res; 2002 Dec; 62(23):6864-9. PubMed ID: 12460900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
    Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
    Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.
    Carney BK; Caruso Silva V; Cassimeris L
    Cytoskeleton (Hoboken); 2012 May; 69(5):278-89. PubMed ID: 22407961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-associated proteins and tubulin interaction by isothermal titration calorimetry.
    Tsvetkov PO; Barbier P; Breuzard G; Peyrot V; Devred F
    Methods Cell Biol; 2013; 115():283-302. PubMed ID: 23973079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.
    Alli E; Yang JM; Ford JM; Hait WN
    Mol Pharmacol; 2007 May; 71(5):1233-40. PubMed ID: 17272681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities.
    Larsson N; Segerman B; Howell B; Fridell K; Cassimeris L; Gullberg M
    J Cell Biol; 1999 Sep; 146(6):1289-302. PubMed ID: 10491392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stathmin/Op18 phosphorylation is regulated by microtubule assembly.
    Küntziger T; Gavet O; Manceau V; Sobel A; Bornens M
    Mol Biol Cell; 2001 Feb; 12(2):437-48. PubMed ID: 11179426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for the catastrophe-promoting activity of the microtubule destabilizer Op18/stathmin.
    Gupta KK; Li C; Duan A; Alberico EO; Kim OV; Alber MS; Goodson HV
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20449-54. PubMed ID: 24284166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of oncoprotein 18/stathmin identify tubulin-directed regulatory activities distinct from tubulin association.
    Larsson N; Segerman B; Gradin HM; Wandzioch E; Cassimeris L; Gullberg M
    Mol Cell Biol; 1999 Mar; 19(3):2242-50. PubMed ID: 10022911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
    Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin.
    Howell B; Larsson N; Gullberg M; Cassimeris L
    Mol Biol Cell; 1999 Jan; 10(1):105-18. PubMed ID: 9880330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.
    Smith JA; Wilson L; Azarenko O; Zhu X; Lewis BM; Littlefield BA; Jordan MA
    Biochemistry; 2010 Feb; 49(6):1331-7. PubMed ID: 20030375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the cellular functions of the Op18/Stathmin family of microtubule-regulators by plasma membrane-targeted localization.
    Holmfeldt P; Brannstrom K; Stenmark S; Gullberg M
    Mol Biol Cell; 2003 Sep; 14(9):3716-29. PubMed ID: 12972559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics.
    Waight AB; Bargsten K; Doronina S; Steinmetz MO; Sussman D; Prota AE
    PLoS One; 2016; 11(8):e0160890. PubMed ID: 27518442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of tubulin with a new fluorescent analogue of vinblastine.
    Chatterjee SK; Laffray J; Patel P; Ravindra R; Qin Y; Kuehne ME; Bane SL
    Biochemistry; 2002 Nov; 41(47):14010-8. PubMed ID: 12437358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation.
    Alday PH; Correia JJ
    Biochemistry; 2009 Aug; 48(33):7927-38. PubMed ID: 19586046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global regulation of the interphase microtubule system by abundantly expressed Op18/stathmin.
    Sellin ME; Holmfeldt P; Stenmark S; Gullberg M
    Mol Biol Cell; 2008 Jul; 19(7):2897-906. PubMed ID: 18434595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1.
    Wittmann T; Bokoch GM; Waterman-Storer CM
    J Biol Chem; 2004 Feb; 279(7):6196-203. PubMed ID: 14645234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.